1997
DOI: 10.1016/s0140-6736(96)11043-6
|View full text |Cite
|
Sign up to set email alerts
|

Randomised controlled trial of anterior-chamber intraocular lenses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0
1

Year Published

2002
2002
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(29 citation statements)
references
References 11 publications
0
28
0
1
Order By: Relevance
“…Advantages of the ACIOL over PCIOL include the ease of insertion and relative minimal time consumption for secure IOL placement. Prospective data comparing open-loop ACIOL insertion in intracapsular cataract extraction with no IOL insertion [16] indicate the risk attributable specifically to the insertion of an open-loop ACIOL. This randomised controlled trial indicated there was no statistically significant increase in patients developing cystoid macular oedema or corneal decompensation compared with no IOL, with a statistically significant increase in glaucoma escalation; however, as such a small number were affected, this was concluded unlikely to be of clinical significance.…”
Section: Anterior Chamber Intraocular Lensesmentioning
confidence: 99%
“…Advantages of the ACIOL over PCIOL include the ease of insertion and relative minimal time consumption for secure IOL placement. Prospective data comparing open-loop ACIOL insertion in intracapsular cataract extraction with no IOL insertion [16] indicate the risk attributable specifically to the insertion of an open-loop ACIOL. This randomised controlled trial indicated there was no statistically significant increase in patients developing cystoid macular oedema or corneal decompensation compared with no IOL, with a statistically significant increase in glaucoma escalation; however, as such a small number were affected, this was concluded unlikely to be of clinical significance.…”
Section: Anterior Chamber Intraocular Lensesmentioning
confidence: 99%
“…[17][18][19] Randomised clinical trials have proven their safety. 20,21 Secondly, the cost of high-quality IOL has fallen as they are manufactured in developing countries such as India, Nepal, and Eritrea. Single-piece PMMA IOL are available for less than d2, which is cheaper than aphakic glasses.…”
Section: Surgerymentioning
confidence: 99%
“…It has been successfully implanted in children with congenital cataract, myopic anisometropic amblyopia, and subluxated lenses. 1,7,8 However, concerns regarding chronic endothelial cell loss (ECL) and the risk of lens de-enclavation from the iris have continued, in part, owing to lack of data in the literature for these cases.…”
Section: Introductionmentioning
confidence: 99%